Connect your AI

Neogen NEOG Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Maravai LifeSciences Holdings, Inc.MRVI

$1.61M-26.6%

Other financials

Income statement

Revenue$211.2M-4.4%

Gross profit$99.0M-10.2%

Operating income-$3.3M-161%

Net income-$17.0M-56.0%

EPS (diluted)-$0.08-60.0%

Balance sheet

Cash & equivalents$159.9M+25.2%

Total debt$793.3M-11.2%

Total equity$2.1B-21.0%

Total assets$3.4B-16.8%

Cash flow

Operating cash flow$22.7M+16.7%

CapEx$11.6M-64.7%

Free cash flow$11.1M+182%

Valuation

Market cap$2.07B+93.1%

Enterprise value$2.7B+45.5%

P/S2.4×+1.2×

Profitability

Gross margin45.2%-3.6pp

Operating margin-73.1%+77.7pp

Net margin-69.9%+30.8pp

FCF margin-14%—

Returns & leverage

Return on equity-25.6%+28.8pp

Debt / equity0.4×0.0×

Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Neogen’s 10-K, filed July 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Neogen's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Neogen's non-cash lease expense?: Neogen (NEOG) reported non-cash lease expense of $1.55M in Q1 2025.
How has Neogen's non-cash lease expense changed year-over-year?: Neogen's non-cash lease expense increased by 37.2% year-over-year, from $1.13M to $1.55M.
What is the long-term trend for Neogen's non-cash lease expense?: Over 3 years (2022 to 2025), Neogen's non-cash lease expense has grown at a 141.8% compound annual growth rate (CAGR), from $438K to $6.19M.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.